Global Reproductive Health Target expanded IVF clinics and reproductive health centers leveraging Vitrolife Group’s end-to-end solutions in medical devices and genetic testing to widen footprint in markets where Igenomix presence is growing.

Acquisition Momentum Position partnerships with recently acquired assets such as eFertility International and Igenomix to offer integrated workflows, enabling cross-sell of genetic testing services with hardware and consumables.

Operational Leadership With leadership changes including a new COO and interim CFO, offer consulting, implementation services, and change-management packages to ensure smooth adoption of Vitrolife technology stacks in clinics.

Tech-Driven Efficiency Leverage the existing tech stack (Salesforce, Boomi, OneTrust, COBIT, VMware) to propose streamlined CRM, data integration, compliance, and deployment accelerators for clinics aiming to scale IVF programs.

Geographic Expansion Identify high-potential markets where Vitrolife is not yet fully served, offering local partnerships and distributor-backed initiatives to accelerate product availability in over 125 countries.